House Panel Excludes 340B User Fee from FY 2013 Funding Bill

by Admin | July 23, 2012 12:38 pm

July 23, 2012—The House health appropriations subcommittee has declined to include language in its fiscal 2013 funding bill[1] for the Department of Health and Human Services (HHS) that would authorize the collection of user fees on 340B discounted drugs. Its July 18 action came about a month after the Senate Appropriations Committee passed an HHS spending bill that would authorize the fees[2].

A 340B user fee has been an important priority for the Health Resources and Services Administration (HRSA) for a number of years and would be used to finance its Office of Pharmacy Affairs (OPA). 

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[3].    Already registered? Click here to login[4]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

 

Source URL: https://340binformed.org/2012/07/house-panel-excludes-340b-user-fee-from-fy-2013-funding-bill/

---